Cite
HARVARD Citation
Ma, R. et al. (2018). Corrigenda: Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neuro-oncology practice. 5 (2), p. 72. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, R. et al. (2018). Corrigenda: Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neuro-oncology practice. 5 (2), p. 72. [Online].